222 related articles for article (PubMed ID: 8712938)
1. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
Korshunov AG; Sycheva RV
Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of the interconnections between the proliferative activity of benign and anaplastic astrocytomas of the cerebral hemispheres and their histological structural characteristics].
Korshunov AG; Sycheva RV
Zh Vopr Neirokhir Im N N Burdenko; 1997; (1):30-4. PubMed ID: 9148628
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of astrocytic gliomas correlating histological parameters with the proliferating cell nuclear antigen labelling index (PCNA-LI).
Cruz-Sánchez FF; Ferreres JC; Figols J; Palacin A; Cardesa A; Rossi ML; Val-Bernal JF
Histol Histopathol; 1997 Jan; 12(1):43-9. PubMed ID: 9046042
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of PCNA labeling index in astrocytic tumors].
Beppu T; Arai H; Kanaya H; Sasaki K
No Shinkei Geka; 1992 Dec; 20(12):1255-9. PubMed ID: 1362456
[TBL] [Abstract][Full Text] [Related]
7. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
Patt S; Giraldo M; Martin H
Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
[TBL] [Abstract][Full Text] [Related]
8. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
9. [Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance].
Tan PG; Li ZQ; Cai WQ; Lu JP; Xie FS; Weng Y
Ai Zheng; 2003 Oct; 22(10):1077-80. PubMed ID: 14558955
[TBL] [Abstract][Full Text] [Related]
10. [An immunohistochemical study of the expression of the oncoprotein p53 in astrocytic gliomas of the cerebral hemispheres].
Korshunov AG; Sycheva RV
Arkh Patol; 1996; 58(6):37-42. PubMed ID: 9139592
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms.
Haapasalo HK; Sallinen PK; Helén PT; Rantala IS; Helin HJ; Isola JJ
J Pathol; 1993 Nov; 171(3):207-14. PubMed ID: 7903983
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.
Eneström S; Vavruch L; Frånlund B; Nordenskjöld B
Neurochirurgie; 1998 Mar; 44(1):25-30. PubMed ID: 9757314
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas.
Revesz T; Alsanjari N; Darling JL; Scaravilli F; Lane DP; Thomas DG
Neuropathol Appl Neurobiol; 1993 Apr; 19(2):152-8. PubMed ID: 8100356
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I
Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
17. Significance of MIB-1, PCNA indices, and p53 protein over-expression in intramedullary tumors of the spinal cord.
Iwata K; Nakagawa H; Hashizume Y
Noshuyo Byori; 1996 Apr; 13(1):73-8. PubMed ID: 8916130
[TBL] [Abstract][Full Text] [Related]
18. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
19. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance.
Vigliani MC; Chiò A; Pezzulo T; Soffietti R; Giordana MT; Schiffer D
Tumori; 1994 Aug; 80(4):295-300. PubMed ID: 7974802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]